Researchers show how the brain can protect against cancer

June 9, 2008

Scientists have been aware for many years that if cancer patients are not able to deal with the stress associated with being sick, the cancer will progress faster than in calmer patients. To counteract this phenomenon, physicians encourage treatments that help cancer patients handle their stress. Scientists theorized that the stress relief may have come as a result of increased beta-endorphin peptide (BEP), the "feel good" hormones in the brain that are released during exercise, a good conversation, and many other aspects of life that give humans pleasure.

Researchers at Rutgers hypothesized that BEP producing neurons do not just make us feel good, but also play roles in regulating the stress response and immune functions to control tumor growth and progression. In a paper published today in the Proceedings of the National Academy of Science, Dr. Dipak K. Sarkar and his colleagues demonstrate the physical mechanisms that support their hypothesis.

"Our findings show promise for future therapeutic treatments for bolstering the immune function," said Sarkar, professor of animal sciences and director of the Endocrinology Program at the Rutgers School of Environmental and Biological Sciences, and principal investigator of the research project.

Previous research has shown that too few, or inactive, BEP neurons are associated with various diseases. For example, low numbers of BEP neurons have been identified in the brains of patients with depression and schizophrenia. Neurons that produce too little BEP are found in many obese patients. In both these cases the patients also had higher levels of infection and more incidence of cancer.

To test their hypothesis about the role of BEP in controling tumor growth and progression, the Rutgers scientists took neural stem cells, transformed them into BEP neurons by treating them with particular chemicals, and then transplanted them into brains of live rats. The authors studied tumor growth in the rats that had been given carcinogens to induce prostate tumors. The authors noted that the BEP neurons boosted the immune system by increasing the activity of particular immune cell types and decreasing inflammation.

The neurons also protected the rats against prostate cancer 90 percent of the time. The researchers discovered that the "natural killer," or NK cells that typically attack cancer cells in the body, are activated by the inserted BEP neurons. The NK cells reduced inflammation around the cancer cells, which slowed down caner cell growth and killed many of these cells.

"We are optimistic that this research can be applied to human medicine," said Sarkar. "Instead of transplanting cells, we will investigate whether we can increase BEP using a chemical approach."

Source: Rutgers University


   
Rate this story - 4.4 /5 (35 votes)

Rank Filter

Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

  • am_Unition - Jun 09, 2008
    • Rank: 3.4 / 5 (5)
    "...we will investigate whether we can increase BEP using a chemical approach."

    Great. Another BS pharmaceutical market.

    Instead of people treating themselves through self-empowerment, psychiatric, and natural remedies, we'll make fortunes off new pills that are most likely not much more than a placebo effect.

    It's ok to rate this comment low.
  • Chroma - Jun 09, 2008
    • Rank: not rated yet
    I agree. It's not magic to say that we can heal ourselves if we practice healthy habits, exercise your body, exercise your mind. A medication like this should be used in extreme situations, and in moderation.

June 9, 2008 all stories

Comments: 2

4.4 /5 (35 votes)



  • hide
  • Relevant PhysicsForums posts

Other News

Scientists reveal how an old drug could have a new use for treating river blindness

Medicine & Health / Research

created 39 minutes ago | popularity not rated yet | comments 0 | with audio podcast

Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the ...


Using nitroglycerin to treat prostate cancer shows potential to halt disease

Medicine & Health / Cancer

created 49 minutes ago | popularity 5 / 5 (1) | comments 0

Treatment of prostate cancer using a very low dose of nitroglycerin may slow and even halt the progression of the disease without the severe side effects of current treatments, Queen's University researchers have discovered


New era of pain drugs advanced by Barrow researcher

Medicine & Health / Neuroscience

created 36 minutes ago | popularity not rated yet | comments 0

Research led by a scientist at Barrow Neurological Institute at St. Joseph's Hospital and Medical Center has opened the door for the advancement of a new category of painkillers, called TRPV1 antagonists.


Phone app providing real-time statistics on physical activity around the world

Medicine & Health / Health

created 5 minutes ago | popularity not rated yet | comments 0

An iPhone application created by UH researchers is providing first-of-its-kind real-time statistics of physical activity around the world. Those annual rankings of America's fattest and fittest cities that use government ...


Research warns of risks of low potassium in heart failure patients with chronic kidney disease

Medicine & Health / Diseases

created 48 minutes ago | popularity not rated yet | comments 0

New research from the University of Alabama at Birmingham (UAB) says low potassium levels produce an increased risk of death or hospitalization in patients with heart failure and chronic kidney disease (CKD).